Fujinami & etal. Clinical and Molecular Characteristics of Childhood-Onset Stargardt Disease. Ophthalmology. 2015:122(2):326-334.
Duponsel N. Socio-demographic, visual and psychological factors associated with adjustment to vision loss in retinitis pigmentosa. Institutional Repository. 2012:5(8):132-141.
Bartlett & etal. Psychological interventions for parents of children and adolescents with chronic illness. Pain research. 2015:4(2):123-131.
Sabel B, Wang J, Morales L, Faig M, Heim C. Mental stress as consequence and cause of vision loss: the dawn of psychosomatic ophthalmology for preventive and personalized medicine. EPMA Journal. 2018:3(9):133-160.
Yorke & etal. Feasibility and acceptability of group‐CBT for people with severe asthma. European respiratory journal. 2013:42(57):1-12.
Nashed M, Dulay V, Yorke J, Kew K. Cognitive behavioural therapy (CBT) for adults and adolescents with asthma. The Cochrane database of systematic reviews.2016: 22 (9):113-118.
Dnezo & etal. The Effectiveness of Cognitive-Behavioral Therapy on Anxiety and depression in stargardt Patients.BMJ. 2015:12(3):231-239.
Rotenstrich Y, Fishman G, Anderson R. Visual acuity loss and clinical observations in a large series of patients with stargardt disease. Ophthalmolegy. 2003:110(6):1151-1158.
Moschos M, Nitoda E, Lavaris A. Estimation of Depression Prevalence in Patients with Stargardt Disease using PHQ-9 and Zung Scores. European Journal of Ophthlmology. 2015:30(11):251-261.
Vander & etal. Stepped care for depression and anxiety in visually impaired older adults: multicentre randomised controlled trial.BMJ. 2016:35(1):125-132.
Bryan J, Leror A, Lu Q. The stargardt disease experience: An analysis of expressive writing essays about living with a rare eye disease. New Frontiers in Ophthalmology. 2016:2(1):57-62.